S2G Investments — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Faeth Therapeutics develops PIKTOR, an oral multi-node inhibitor targeting the PI3K/AKT/mTOR pathway for cancer treatment, currently in clinical trials for endometrial and breast cancer.
BiotechDigital HealthMedical DevicesAustin, US
Anand Parikh(Executive Officer, Director, Promoter)Oliver Maddocks(Executive Officer, Director)
BoardAlex Morgan(Director)Jayson Dallas(Director)Robert Gould(Director)Stephen Hahn(Director)
Advanced ManufacturingNew York, US
Florentino Torres Meneses(Executive Officer)Andreas Grimminger(Executive Officer, Director)David Juracich(Executive Officer, Director)Luis Fernando Mendez Dupont(Executive Officer)
BoardFrancisco Saraiva Gomes(Director)Larsen Mettler(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.